AbbVie, a leading pharmaceutical company, has initiated a new USD 223 million expansion of its manufacturing facility in Singapore’s Tuas Biomedical Park. This investment aims to bolster AbbVie’s global manufacturing capacity for biologics, generating over...
A European-based wellness center is targeting Sabah as a strategic location for its expansion into the ASEAN market, particularly in the wellness and biopharmaceutical sectors. Dr Mike Chan, Chairman of the European Wellness Biomedical Group based in Germany,...
In January 2024, the 3D Technology in Medicine Center (3D Lab) of VinUniversity, a private university in Vietnam, signed a Memorandum of Understanding (MoU) with CustoMED – Sheba Medical Center, from Israel. This milestone marks a significant advancement in the...
The Department of Health (DOH) aims to enhance healthcare accessibility for impoverished Filipinos by constructing 28 National Ambulatory and Urgent Care Facilities across strategic locations nationwide by 2028. Health Secretary Teodoro Herbosa highlighted the goal to...
It has been revealed that American company Crowell & Moring International (CMI) is working with the Indonesian Ministry of Health to develop a plan to eliminate cervical cancer, one of the leading types of cancer-related death among women in the Southeast Asian...
Malaysian pharmaceutical company, Novugen Oncology Sdn Bhd has secured approval from the US Food and Drug Administration (USFDA) for its specialized manufacturing facility focusing on high-potency oncology drugs. Novugen as the first and only entity in Malaysia and...
The UK’s Department for Business and Trade (DBT) and the British Embassy in Manila hosted a Trade Mission last 29 November – 1 December composed of National Health Service (NHS) Organisations who met with healthcare leaders in the Philippines to explore collaborations...
Elekta, a global Swedish company that develops and produces radiation therapy and radiosurgery-related equipment and clinical management for the treatment of cancer and brain disorders, recently announced the establishment of a new office in Bangkok to support...
Nipro, Japan’s multinational medical corporation, has recently partnered with FPT Telecom’s FPT Medicare on a strategic cooperation agreement to deliver digital medical devices with international standards and affordability. Through this partnership, the two firms aim...
ImmunoScape, a biotechnology company focused on next-generation T Cell receptor (TCR)-based immunotherapies, has announced a partnership with the Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development hosted by...
GC Biopharma, a South Korean biopharmaceutical company, recently started the construction of a plasma fractionation plant at the Jababeka Industrial Estate in Indonesia. This initiative is part of the company’s broader efforts in constructing overseas plants....
The Asian Development Bank (ADB) has approved an investment of USD 650 million for the upgrade of Indonesia’s primary healthcare facilities and public health laboratories. This marks the third phase of ADB’s support for post-pandemic health reforms in...
